Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/1993
10/14/1993WO1993020211A1 A method of limiting the survival of genetically engineered microorganisms in their environment
10/14/1993WO1993020210A1 Antibodies for treatment and prevention of respiratory syncytial virus infection
10/14/1993WO1993020197A1 Stem cell proliferation factor
10/14/1993WO1993020196A1 Cloning, expression and uses of a novel secreted protein, f-spondin
10/14/1993WO1993020189A1 Process for the production of a viable cell culture infected by a multiple sclerosis associated virus
10/14/1993WO1993020188A1 Process and culture medium for the production of cells infected by a multiple sclerosis associated virus
10/14/1993WO1993020187A1 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
10/14/1993WO1993020186A1 In vitro generation of human dendritic cells and uses thereof
10/14/1993WO1993020185A1 Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens
10/14/1993WO1993020184A1 Method for culturing hematopoietic cells
10/14/1993WO1993020093A1 Hybrid human/porcine factor viii
10/14/1993WO1993019786A1 High affinity, strongly neutralizing monoclonal antibodies against the cd-4 binding site of gp120 of human immunodeficiency virus
10/14/1993WO1993019785A1 Recombinant human hiv-neutralizing monoclonal antibodies for prevention and treatment of hiv infection
10/14/1993WO1993019782A1 Specific detection of cell surface receptor leukocyte adhesion molecule-1
10/14/1993WO1993019770A1 Compositions for the treatment of acute or chronic inflammation
10/14/1993WO1993019767A1 Cd28 pathway immunoregulation
10/14/1993WO1993019605A1 Evaluation and treatment of patients with progressive immunosuppression
10/14/1993WO1993019585A1 Induction of somatic embryogenesis in taxus, and the production of taxane-ring containing alkaloids therefrom
10/14/1993CA2133662A1 Antibodies for treatment and prevention of respiratory syncytial virus infection
10/14/1993CA2133443A1 Cloning, expression and uses of a novel secreted protein, f-spondin
10/14/1993CA2133075A1 CD28 Pathway Immunoregulation
10/14/1993CA2131532A1 Induction of somatic embryogenesis in taxus, and the production of taxane-ring containing alkaloids therefrom
10/14/1993CA2117884A1 Non-infectious hiv particles and uses therefor
10/13/1993EP0565370A1 Serotonin receptor protein and related DNA compounds
10/13/1993EP0565172A1 Cloning and expression of DNA encoding a ripening form of a polypeptide having sulfhydryl oxidase activity
10/13/1993EP0564646A1 Trapped cells and use thereof as a drug
10/13/1993EP0564645A1 Transformant cells for the prophylaxis or treatment of diseases caused by viruses, particularly pathogenic retroviruses
10/13/1993EP0564595A1 Stable transformation of maize cells by electroporation.
10/13/1993EP0564592A1 Liver enriched transcription factor
10/13/1993EP0564539A1 Sustained and continuous production of high titers of recombinant viral vectors and transduced target cells for use in gene therapy
10/13/1993EP0564531A1 Enrichment method for variant proteins with altered binding properties
10/13/1993EP0564513A1 TAPETUM-SPECIFIC PROMOTERS FROM $i(BRASSICACEAE) SPP
10/13/1993EP0564502A1 Tissue sealant and growth factor containing compositions that promote accelerated wound healing
10/13/1993EP0318487B1 Serum free tissue culture medium containing polymeric cell-protective agent
10/12/1993US5252480 Human monoclonal antibody and hybridoma producing the same
10/12/1993US5252479 Safe vector for gene therapy
10/11/1993CA2093575A1 Human antithrombin iii mutant
10/10/1993WO1993021305A1 MONOCLONAL ANTIBODY TO CELL SURFACE PROTEIN OF THE BACTERIUM $i(STREPTOCOCCUS PNEUMONIAE)
10/10/1993CA2117794A1 Monoclonal antibody to cell surface protein of the bacterium streptococcus pneumoniae
10/10/1993CA2093506A1 Serotonin receptor protein and related dna compounds
10/08/1993CA2434692A1 Callus cell induction and the preparation of taxanes
10/07/1993DE4222407C1 Modulartiges Promotor-Konstrukt A modular promoter construct
10/06/1993EP0563487A1 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
10/06/1993EP0563485A1 In vitro generation of human dendritic cells and uses thereof
10/06/1993EP0563296A1 Optimization of binding proteins
10/06/1993EP0563239A1 A truncated interleukin-1 receptor gene for the treatment of arthritis
10/06/1993EP0563189A1 Genetically engineered modification of potato to form amylopectin-type starch
10/06/1993EP0563161A1 Plant dna
10/06/1993EP0563157A1 Dna, dna constructs, cells and plants derived therefrom
10/06/1993EP0563089A1 Serotonine receptor of class 1: the 5-ht 1x? receptors
10/06/1993EP0556345A4 Retroviral vectors useful for gene therapy
10/06/1993EP0454778A4 Molecules with antibody combining sites that exhibit stereospecific catalysis
10/06/1993EP0429497B1 Cocumber mosaic virus coat protein gene
10/06/1993CN1076966A Cloning and expression of humanized monoclonal antibodies against human interleukin-4
10/06/1993CN1076865A A novel process for preparing a vaccine for hemorrhagic fever with renal syndrome
10/05/1993US5250661 Established cell line
10/05/1993US5250433 Gramineous hybrid plants and process for preparing them
10/05/1993US5250432 Suspension culture with removal of culture fluid, separation and return of cells
10/05/1993US5250421 Culturing mammalian cells transfected with DNA expression vector coding in serum free medium containing phospholipid
10/02/1993CA2093099A1 Recombinant human hiv-neutralizing monoclonal antibodies for prevention and treatment of hiv infection
09/1993
09/30/1993WO1993019372A1 Method of detecting microorganisms
09/30/1993WO1993019197A1 Human monoclonal antibodies and methods for human monoclonal antibody production
09/30/1993WO1993019191A1 Defective recombinant adenoviruses expressing cytokines for use in antitumoral treatment
09/30/1993WO1993019190A1 Nucleic acid fragments and methods for increasing the lysine and threonine content of the seeds of plants
09/30/1993WO1993019189A1 Enhanced expression in plants
09/30/1993WO1993019188A1 Fungus-responsive chimaeric gene
09/30/1993WO1993019187A1 Transgenic plants displaying multiple virus resistance and a process for their production
09/30/1993WO1993019180A1 Genetically engineered antibodies
09/30/1993WO1993019179A1 Ifn receptors recognition factors, protein sequences and methods of use thereof
09/30/1993WO1993019175A1 Receptor for the glucagon-like-peptide-1 (glp-1)
09/30/1993WO1993019168A1 Reconstituted cartilage tissue
09/30/1993WO1993019165A1 Colon crypt cell mitogen, cell line producing it, and uses thereof
09/30/1993WO1993019161A1 Method for producing high cell densities
09/30/1993WO1993019094A1 A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses
09/30/1993WO1993018649A1 Graft copolymers of polycationic species and water-soluble polymers, and uses thereof
09/30/1993WO1993018648A1 In vitro-derived human neutrophil precursor cells
09/30/1993WO1993016185A3 Biosynthetic binding protein for cancer marker
09/30/1993CA2132323A1 Fungus-responsive chimaeric gene
09/30/1993CA2132317A1 Ifn receptors recognition factors, protein sequences and methods of use thereof
09/30/1993CA2132095A1 Colon crypt cell mitogen, cell line producing it, and uses thereof
09/30/1993CA2130173A1 Genetically engineered antibodies
09/30/1993CA2109729A1 In vitro-derived human neutrophil precursor cells
09/29/1993EP0562132A1 Monoclonal anti-tetanus toxin antibodies and pharmaceutical compositions containing them
09/29/1993EP0562123A1 Novel physiologically active substance epimorphine, gene which codes for same, and antibody against epimorphine
09/29/1993EP0562013A1 Human retrovirus receptor and dna coding therefor
09/29/1993EP0561965A1 Enhancement of musculature in animals
09/29/1993EP0561890A1 Dna expression systems based on alphaviruses
09/28/1993CA1322541C Method for releasing cell cultures from the microcarriers
09/23/1993DE4208429A1 Verfahren zur erzeugung hoher zelldichten Process for the production of high cell density
09/22/1993EP0561549A2 Method and apparatus for purifying islets of langerhans
09/22/1993EP0561525A1 Process for the expression of herpes simplex virus type 1 glycoprotein E and methods of use
09/22/1993EP0561496A2 cDNAs encoding the gastrin and CCK-B receptors
09/22/1993EP0561427A1 Monoclonal antibodies to new factor VIII coagulant polypeptides
09/22/1993EP0561183A1 Anti-ganglioside monoclonal antibody, its preparation and use as a tumour therapeutic agent
09/22/1993EP0561140A1 Methods for pharmacokinetical studies of insulin expression involving transgenic mammal
09/22/1993EP0561082A1 Methods of regeneration of medicago sativa and expressing foreign DNA in same
09/22/1993EP0561034A2 Direct molecular cloning of a modified eukaryotic cytoplasmic DNA virus genome
09/22/1993EP0560865A1 Wound dressings and processes for manufacture thereof
09/21/1993US5246831 Feline infectious peritonitis virus test utilizing monoclonal idiotypic and anti-idiotypic antibodies
09/21/1993US5246829 Antigen-coated beads